CDKN1A and neoplasm: P21, a member of the Cip/Kip family, acts as a regulator of multiple tumor suppressor pathways for anti-proliferative activities via mediating biological activities primarily by binding to and inhibiting the kinase activity of the cyclin-dependent kinases (CDKs) [35,36].